Cargando…
Oncolytic viral immunotherapy in the time of COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610094/ https://www.ncbi.nlm.nih.gov/pubmed/33183956 http://dx.doi.org/10.1016/j.cytogfr.2020.10.009 |
| _version_ | 1783605131956191232 |
|---|---|
| author | Olagnier, David Alain, Tommy |
| author_facet | Olagnier, David Alain, Tommy |
| author_sort | Olagnier, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7610094 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76100942020-11-05 Oncolytic viral immunotherapy in the time of COVID-19 Olagnier, David Alain, Tommy Cytokine Growth Factor Rev Article Published by Elsevier Ltd. 2020-12 2020-11-04 /pmc/articles/PMC7610094/ /pubmed/33183956 http://dx.doi.org/10.1016/j.cytogfr.2020.10.009 Text en Crown Copyright © 2020 Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Olagnier, David Alain, Tommy Oncolytic viral immunotherapy in the time of COVID-19 |
| title | Oncolytic viral immunotherapy in the time of COVID-19 |
| title_full | Oncolytic viral immunotherapy in the time of COVID-19 |
| title_fullStr | Oncolytic viral immunotherapy in the time of COVID-19 |
| title_full_unstemmed | Oncolytic viral immunotherapy in the time of COVID-19 |
| title_short | Oncolytic viral immunotherapy in the time of COVID-19 |
| title_sort | oncolytic viral immunotherapy in the time of covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610094/ https://www.ncbi.nlm.nih.gov/pubmed/33183956 http://dx.doi.org/10.1016/j.cytogfr.2020.10.009 |
| work_keys_str_mv | AT olagnierdavid oncolyticviralimmunotherapyinthetimeofcovid19 AT alaintommy oncolyticviralimmunotherapyinthetimeofcovid19 |